A cataract expert discussed if postoperative topical antibiotics add protection after intracameral prophylaxis.
Publication|Articles|August 12, 2026
- Ophthalmology Times: July/August 2026
- Volume 51
- Issue 4
Single-use instruments: Beyond the backup role
Fact checked by: Sheryl Stevenson
Waste, cost, and carbon are converging to reshape how cataract centers choose instruments.
Advertisement
Advertisement
In the modern ophthalmic surgical center, clinical efficiency, sustainability, and economic viability often represent intertwined but diverging goals. Cataract surgery, the most commonly performed ophthalmic procedure globally, lies at the heart of these issues. Amid growing concerns related to clinical waste and carbon emissions, the question of whether to use reusable instruments (RUIs) or single-use instruments (SUIs) is more pertinent than ever.
Related to this article
Anjum F. Koreishi, MD, explains why inflammation control and planning are key to cataract surgery for patients with uveitis.
David F. Chang, MD, explained how offering complementary refractive IOLs reduces patient anxiety and indecision.
Liza M. Cohen, MD, explains when to use CT vs MRI in thyroid eye disease and why to review images yourself.
Ehsan Rahimy, MD, says most PRIMA serious adverse events occurred early, while vision gains held through 36 months.
Vaidehi Dedania, MD, shared what the first whole eye transplant revealed about reperfusion, retinal cells, and sight.
Twice-daily clobetasol 0.05% cleared cells in 26.5% vs 8.6% of patients and pain in 75.1% vs 32.4% after cataract surgery, with no added endothelial cell loss.
Initial phaco for angle-closure glaucoma climbed to 48.4% in adults 50 and older, while surveys and IRIS data show shifting trabeculectomy and JOAG surgical patterns.
Advertisement
Advertisement